It looks like a high risk but also high reward bet. It is a prodrug of cyclosporine so it should work
The Feb 8 open label result gives me a little bit more confidence. It is an 2016 SI biotech charity contest pick by 6 people, somewhat popular. Ohad Hammer has it in his portfolio, FWIW. I have a small amount in my portfolio so my opinion is biased.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.